Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
omacetaxine mepesuccinate
Teva Pharma GmbH
Hematologic Malignancies
1 trial -
Anshen Buxin Liuwei Pill
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiac Neurosis
1 trial -
Botulinum Toxin A
United Therapeutics Europe Ltd
Low Back Pain
1 trial -
Botulinum Toxin Type B
SUPERNUS PHARMACEUTICALS, INC.
Cervical Dystonia
1 trial -
DIGOXIN
Disc Medicine
heart failure
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
Digaoxin,amiodarone,Ξ² receptor antagonist, Calcium Antagonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial -
Digoxin
Teva Pharma GmbH
Heart Failure
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Levothyroxine
United Therapeutics Europe Ltd
Hypothyroidism
1 trial -
Levothyroxine
The First People's Hospital of Lianyungang
Heart Failure
1 trial -
SILDENAFIL , LEVOTHYROXINE SODIUM
The George Institute
erectile function, hypothyroidism subclinic
1 trial -
Shexiang Baoxin pill
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease(CAD)
1 trial -
Shexiang Baoxin pillοΌMUSKARDIAοΌ
Disc Medicine
Ischemia With Non-Obstructive Coronary Artery
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Malaria (Uncomplicated)
1 trial -
Topiramate
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Alcohol Dependence
1 trial -
VENLAFAXINE
Disc Medicine
Major Depressive Disorder
1 trial -
Wen Xin granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial -
Xingnaojing injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Xingnaojing injection
Universal Integrated
Acute Ischemic Stroke
1 trial -
Xinnaoning Capsule
BRIGHT MINDS BIOSCIENCES INC.
Chronic Stable Angina Pectoris
1 trial -
Xueshuanxinmaining tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources